Royal Bank of Canada Buys 274,785 Shares of Acadia Healthcare Company, Inc. $ACHC

Royal Bank of Canada increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7,896.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 278,265 shares of the company’s stock after purchasing an additional 274,785 shares during the period. Royal Bank of Canada’s holdings in Acadia Healthcare were worth $6,508,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ACHC. The Manufacturers Life Insurance Company boosted its holdings in Acadia Healthcare by 30.1% during the first quarter. The Manufacturers Life Insurance Company now owns 17,911 shares of the company’s stock worth $419,000 after buying an additional 4,140 shares during the last quarter. Maverick Capital Ltd. increased its stake in shares of Acadia Healthcare by 45.1% in the 1st quarter. Maverick Capital Ltd. now owns 1,314,116 shares of the company’s stock valued at $30,737,000 after acquiring an additional 408,697 shares during the last quarter. Quantinno Capital Management LP raised its position in shares of Acadia Healthcare by 25.5% in the 1st quarter. Quantinno Capital Management LP now owns 117,676 shares of the company’s stock valued at $2,752,000 after acquiring an additional 23,913 shares during the period. Clough Capital Partners L P acquired a new stake in shares of Acadia Healthcare in the 1st quarter valued at approximately $5,359,000. Finally, Waverly Advisors LLC bought a new position in Acadia Healthcare during the 1st quarter worth approximately $344,000.

Acadia Healthcare Stock Down 2.1%

Shares of ACHC stock opened at $31.10 on Wednesday. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $35.83. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The firm has a fifty day moving average of $29.32 and a 200-day moving average of $24.74. The company has a market capitalization of $2.90 billion, a price-to-earnings ratio of -2.50, a P/E/G ratio of 10.31 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. The business had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm’s revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities research analysts predict that Acadia Healthcare Company, Inc. will post 1.54 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have commented on ACHC shares. TD Cowen upped their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Cantor Fitzgerald reissued a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday, July 29th. Royal Bank Of Canada boosted their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. KeyCorp upped their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Finally, Jefferies Financial Group raised Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $29.85.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.